Australia markets closed

Suven Pharmaceuticals Limited (SUVENPHAR.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
803.75+18.85 (+2.40%)
At close: 03:29PM IST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
3,002,806
3,002,806
4,112,903
4,538,049
3,623,418
-
Depreciation & amortisation
518,059
518,059
464,599
382,550
312,207
-
Stock-based compensation
19,662
19,662
-
-
-
-
Change in working capital
474,118
474,118
57,684
-1,939,661
-121,731
-
Inventory
816,149
816,149
-293,932
-823,369
-262,082
-
Other working capital
3,066,962
3,066,962
1,712,836
2,548,135
2,717,005
-
Other non-cash items
55,163
55,163
57,247
61,624
88,758
-
Net cash provided by operating activities
3,584,831
3,584,831
4,571,958
3,300,002
3,825,465
-
Cash flows from investing activities
Investments in property, plant and equipment
-517,869
-517,869
-2,859,122
-751,867
-1,108,460
-
Purchases of investments
-3,135,533
-3,135,533
-44
-3,002,743
-2,005,831
-
Sales/maturities of investments
11,100
11,100
844,553
2,440,974
-
-
Other investing activities
422
422
5,521
-48,439
-27
-
Net cash used for investing activities
-3,622,532
-3,622,532
-1,950,056
-1,361,383
-3,113,982
-
Net change in cash
-175,724
-175,724
202,390
373,812
-45,133
-
Cash at beginning of period
648,028
648,028
445,638
71,822
116,953
-
Cash at end of period
472,312
472,312
648,028
445,638
71,822
-
Free cash flow
Operating cash flow
3,584,831
3,584,831
4,571,958
3,300,002
3,825,465
-
Capital expenditure
-517,869
-517,869
-2,859,122
-751,867
-1,108,460
-
Free cash flow
3,066,962
3,066,962
1,712,836
2,548,135
2,717,005
-